Common variations in platelet glycoproteins: pharmacogenomic implications
about
sameAs
Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factorPharmacogenomics and drug response in cardiovascular disordersTherapeutic approaches in arterial thrombosisThe variability of platelet response to aspirin and clopidogrel: revisiting the Caprie, Cure, Credo, and Match trials.Aspirin and clopidogrel resistance: an emerging clinical entityLack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery diseaseAspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphismExploratory aspirin resistance trial in healthy Japanese volunteers (J-ART) using platelet aggregation as a measure of thrombogenicityGenome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists.Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Antiplatelet drugs: mechanisms and risks of bleeding following cardiac operationsAntiplatelet drug resistance: not ready for prime time.Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularizationAntiplatelet therapy and vascular disease: an update.Polymorphisms and high on-aspirin platelet reactivity after off-pump coronary artery bypass grafting.
P2860
Q28167780-D2586FEB-0C70-4AE3-90E3-479D22D33970Q28171051-34A4AEF1-943D-4EEC-BFDF-F242961CF97CQ28187576-62887643-741D-4635-9E90-6E3C89151786Q28192919-AF1F82A4-E188-4F90-9708-FF41E8C369D4Q28194021-E72679F6-CAE3-4CEE-B330-CBD654DBCB52Q28211198-9AF20A83-D039-44F3-8EFC-61032628BE85Q28217995-742B44DF-4544-4165-98CE-C0B5E6BE9384Q28218177-0F5A5521-0905-4C1E-B821-6A5A5BA7642EQ34674600-C03F421A-68D0-4C65-A785-D8C33FAFCF02Q34771381-43790F57-477D-442E-ABA9-038EE69BBAA2Q35902517-F0270FB3-DFC5-43F2-9C18-AD919F5DFC19Q36289432-7C0AC17C-376C-4541-93FE-7CD4026B31E2Q37167506-BCCF04C8-7A2E-48F0-873C-9A6F903392ADQ37838100-7AEC5710-0427-4450-85B0-5357D462FC7DQ50979736-65935368-6A3E-4E64-A596-072F6DB098B5
P2860
Common variations in platelet glycoproteins: pharmacogenomic implications
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Common variations in platelet glycoproteins: pharmacogenomic implications
@ast
Common variations in platelet glycoproteins: pharmacogenomic implications
@en
Common variations in platelet glycoproteins: pharmacogenomic implications
@nl
type
label
Common variations in platelet glycoproteins: pharmacogenomic implications
@ast
Common variations in platelet glycoproteins: pharmacogenomic implications
@en
Common variations in platelet glycoproteins: pharmacogenomic implications
@nl
prefLabel
Common variations in platelet glycoproteins: pharmacogenomic implications
@ast
Common variations in platelet glycoproteins: pharmacogenomic implications
@en
Common variations in platelet glycoproteins: pharmacogenomic implications
@nl
P2860
P356
P1433
P1476
Common variations in platelet glycoproteins: pharmacogenomic implications
@en
P2093
P2860
P304
P356
10.1517/14622416.2.4.341
P407
P50
P577
2001-11-01T00:00:00Z